BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ricard JD, Wolff M, Lacherade JC, Mourvillier B, Hidri N, Barnaud G, Chevrel G, Bouadma L, Dreyfuss D. Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study. Clin Infect Dis 2007;44:250-5. [PMID: 17173226 DOI: 10.1086/510390] [Cited by in Crossref: 95] [Cited by in F6Publishing: 71] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Murray BE, Arias CA, Nannini EC. Glycopeptides (Vancomycin and Teicoplanin), Streptogramins (Quinupristin-Dalfopristin), Lipopeptides (Daptomycin), and Lipoglycopeptides (Telavancin). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier; 2015. pp. 377-400.e4. [DOI: 10.1016/b978-1-4557-4801-3.00030-8] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
2 Miranda J, Tunkel AR. Strategies and new developments in the management of bacterial meningitis. Infect Dis Clin North Am 2009;23:925-43, viii-ix. [PMID: 19909891 DOI: 10.1016/j.idc.2009.06.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
3 Vivas M, Force E, Tubau F, El Haj C, Ariza J, Cabellos C. Effect of dexamethasone on the efficacy of daptomycin in the therapy of experimental pneumococcal meningitis. Int J Antimicrob Agents 2015;46:28-32. [PMID: 25813395 DOI: 10.1016/j.ijantimicag.2015.01.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
4 Blanquer J, Solé-Violán J, Carvajal J, Lucena F. [Community infections that require admission to the ICU]. Med Intensiva 2010;34:388-96. [PMID: 20605269 DOI: 10.1016/j.medin.2010.03.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Pruitt AA. Neurologic infectious disease emergencies. Neurol Clin 2012;30:129-59, viii. [PMID: 22284058 DOI: 10.1016/j.ncl.2011.09.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
6 Di Paolo A, Gori G, Tascini C, Danesi R, Del Tacca M. Clinical pharmacokinetics of antibacterials in cerebrospinal fluid. Clin Pharmacokinet 2013;52:511-42. [PMID: 23605634 DOI: 10.1007/s40262-013-0062-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
7 Tunkel AR, Van De Beek D, Scheld WM. Acute Meningitis. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier; 2010. pp. 1189-229. [DOI: 10.1016/b978-0-443-06839-3.00084-9] [Cited by in Crossref: 12] [Article Influence: 1.0] [Reference Citation Analysis]
8 Moon SY, Chung DR, Kim SW, Chang HH, Lee H, Jung DS, Kim YS, Jung SI, Ryu SY, Heo ST, Moon C, Ki HK, Son JS, Kwon KT, Shin SY, Lee JS, Lee SS, Rhee JY, Kang CI, Peck KR, Song JH. Is adjunctive corticosteroid beneficial in pneumococcal meningitis in a region with high rates of resistance to penicillin and ceftriaxone? J Neurol 2012;259:1453-60. [PMID: 22222857 DOI: 10.1007/s00415-011-6373-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
9 Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015;CD004405. [PMID: 26362566 DOI: 10.1002/14651858.cd004405.pub5] [Cited by in Crossref: 94] [Cited by in F6Publishing: 71] [Article Influence: 13.4] [Reference Citation Analysis]
10 Kullar R, Chin JN, Edwards DJ, Parker D, Coplin WM, Rybak MJ. Pharmacokinetics of single-dose daptomycin in patients with suspected or confirmed neurological infections. Antimicrob Agents Chemother 2011;55:3505-9. [PMID: 21502620 DOI: 10.1128/AAC.01741-10] [Cited by in Crossref: 43] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
11 Hong LT, Goolsby TA, Sherman DS, Mueller SW, Reynolds P, Cava L, Neumann R, Kiser TH. Continuous infusion vs intermittent vancomycin in neurosurgical intensive care unit patients. J Crit Care 2015;30:1153.e1-6. [PMID: 26239323 DOI: 10.1016/j.jcrc.2015.06.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
12 Murray BE, Nannini EC. Glycopeptides (Vancomycin and Teicoplanin), Streptogramins (Quinupristin-Dalfopristin), and Lipopeptides (Daptomycin). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier; 2010. pp. 449-67. [DOI: 10.1016/b978-0-443-06839-3.00031-x] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
13 Popa D, Loewenstein L, Lam SW, Neuner EA, Ahrens CL, Bhimraj A. Therapeutic drug monitoring of cerebrospinal fluid vancomycin concentration during intraventricular administration. J Hosp Infect 2016;92:199-202. [PMID: 26654472 DOI: 10.1016/j.jhin.2015.10.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
14 Cho TA, Venna N. Management of Acute, Recurrent, and Chronic Meningitides in Adults. Neurologic Clinics 2010;28:1061-88. [DOI: 10.1016/j.ncl.2010.03.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
15 Autmizguine J, Moran C, Gonzalez D, Capparelli EV, Smith PB, Grant GA, Benjamin DK Jr, Cohen-Wolkowiez M, Watt KM. Vancomycin cerebrospinal fluid pharmacokinetics in children with cerebral ventricular shunt infections. Pediatr Infect Dis J 2014;33:e270-2. [PMID: 24776517 DOI: 10.1097/INF.0000000000000385] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
16 Weisfelt M, de Gans J, van de Beek D. Bacterial meningitis: a review of effective pharmacotherapy. Expert Opin Pharmacother 2007;8:1493-504. [PMID: 17661731 DOI: 10.1517/14656566.8.10.1493] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
17 Shokouhi S, Alavi Darazam I. Determination of vancomycin trough level in serum and cerebrospinal fluid of patients with acute community-acquired meningitis: a prospective study. J Infect 2014;69:424-9. [PMID: 24973553 DOI: 10.1016/j.jinf.2014.06.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
18 van de Beek D. Corticosteroids for acute adult bacterial meningitis. Médecine et Maladies Infectieuses 2009;39:531-8. [DOI: 10.1016/j.medmal.2009.02.033] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
19 Bijlsma MW, Brouwer MC, Kasanmoentalib ES, Kloek AT, Lucas MJ, Tanck MW, van der Ende A, van de Beek D. Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study. Lancet Infect Dis 2016;16:339-47. [PMID: 26652862 DOI: 10.1016/S1473-3099(15)00430-2] [Cited by in Crossref: 176] [Cited by in F6Publishing: 77] [Article Influence: 25.1] [Reference Citation Analysis]
20 Wilson MR, Roos KL. Infectious Diseases and Impaired Consciousness. Neurologic Clinics 2011;29:927-42. [DOI: 10.1016/j.ncl.2011.07.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Ziai WC, Lewin JJ 3rd. Update in the diagnosis and management of central nervous system infections. Neurol Clin 2008;26:427-68, viii. [PMID: 18514821 DOI: 10.1016/j.ncl.2008.03.013] [Cited by in Crossref: 64] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
22 Giuliano C, Haase KK, Hall R. Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infections. Expert Rev Anti Infect Ther 2010;8:95-106. [PMID: 20014904 DOI: 10.1586/eri.09.123] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
23 Chaudhuri A, Martinez-Martin P, Kennedy PG, Andrew Seaton R, Portegies P, Bojar M, Steiner I; EFNS Task Force. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol 2008;15:649-59. [PMID: 18582342 DOI: 10.1111/j.1468-1331.2008.02193.x] [Cited by in Crossref: 144] [Cited by in F6Publishing: 99] [Article Influence: 10.3] [Reference Citation Analysis]
24 Jung Y, Kim HB. Multidrug-Resistant Gram-Positive Bacterial Infections. Korean J Med 2015;88:487. [DOI: 10.3904/kjm.2015.88.5.487] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
25 Abdinia B, Ahangarzadeh Rezaee M, Abdoli Oskouie S. Etiology and antimicrobial resistance patterns of acute bacterial meningitis in children: a 10-year referral hospital-based study in northwest iran. Iran Red Crescent Med J 2014;16:e17616. [PMID: 25237583 DOI: 10.5812/ircmj.17616] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
26 Nau R, Djukic M, Spreer A, Ribes S, Eiffert H. Bacterial meningitis: an update of new treatment options. Expert Review of Anti-infective Therapy 2015;13:1401-23. [DOI: 10.1586/14787210.2015.1077700] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
27 Arnell K, Enblad P, Wester T, Sjölin J. Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections. J Neurosurg 2007;107:213-9. [PMID: 17918527 DOI: 10.3171/PED-07/09/213] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
28 Honda H, Warren DK. Central Nervous System Infections: Meningitis and Brain Abscess. Infectious Disease Clinics of North America 2009;23:609-23. [DOI: 10.1016/j.idc.2009.04.009] [Cited by in Crossref: 68] [Cited by in F6Publishing: 37] [Article Influence: 5.2] [Reference Citation Analysis]
29 Ratnaraja NV, Hawkey PM. Current challenges in treating MRSA: what are the options? Expert Review of Anti-infective Therapy 2014;6:601-18. [DOI: 10.1586/14787210.6.5.601] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
30 Hofinger D, Davis LE. Bacterial Meningitis in Older Adults. Curr Treat Options Neurol 2013;15:477-91. [DOI: 10.1007/s11940-013-0244-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
31 Nudelman Y, Tunkel AR. Bacterial meningitis: epidemiology, pathogenesis and management update. Drugs 2009;69:2577-96. [PMID: 19943708 DOI: 10.2165/11530590-000000000-00000] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
32 Doan N, Nguyen H, Luyuan L, Shabani S, Gelsomino M, Johnson V. Good Outcomes with the Intraventricular Vancomycin Therapy in a Patient with Ruptured Brain Abscesses. Asian J Neurosurg 2018;13:396-9. [PMID: 29682042 DOI: 10.4103/1793-5482.185065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
33 Brouwer MC, Mcintyre P, Prasad K, van de Beek D, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd004405.pub4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
34 Brouwer MC, Mcintyre P, de Gans J, Prasad K, van de Beek D, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd004405.pub3] [Cited by in Crossref: 57] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
35 Gibson A, Kaplan SL, Vallejo JG. Impact of Serum Vancomycin Trough Levels in the Treatment of Central Nervous System Shunt Infections Caused by Coagulase-Negative Staphylococci. Pediatr Neurosurg 2018;53:243-6. [PMID: 29698961 DOI: 10.1159/000488498] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
36 Nau R, Sörgel F, Eiffert H. Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 2010;23:858-83. [PMID: 20930076 DOI: 10.1128/CMR.00007-10] [Cited by in Crossref: 461] [Cited by in F6Publishing: 197] [Article Influence: 38.4] [Reference Citation Analysis]
37 Heckenberg SG, Brouwer MC, van de Beek D. Bacterial meningitis. Neurologic Aspects of Systemic Disease Part III. Elsevier; 2014. pp. 1361-75. [DOI: 10.1016/b978-0-7020-4088-7.00093-6] [Cited by in Crossref: 48] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
38 Mourvillier B. Critères d’urgence de l’antibiothérapie : autres mesures associées. Médecine et Maladies Infectieuses 2009;39:659-65. [DOI: 10.1016/j.medmal.2009.02.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Pintado V, Pazos R, Jiménez-mejías ME, Rodríguez-guardado A, Gil A, García-lechuz JM, Cabellos C, Chaves F, Domingo P, Ramos A, Pérez-cecilia E, Domingo D. Methicillin-Resistant Staphylococcus aureus Meningitis in Adults: A Multicenter Study of 86 Cases. Medicine 2012;91:10-7. [DOI: 10.1097/md.0b013e318243442b] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
40 Tessier JM, Scheld WM. Principles of antimicrobial therapy. Bacterial Infections of the Central Nervous System. Elsevier; 2010. pp. 17-29. [DOI: 10.1016/s0072-9752(09)96002-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Agrawal S, Nadel S. Acute bacterial meningitis in infants and children: epidemiology and management. Paediatr Drugs 2011;13:385-400. [PMID: 21999651 DOI: 10.2165/11593340-000000000-00000] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
42 Roberts JA, Lipman J, Blot S, Rello J. Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?: . Current Opinion in Critical Care 2008;14:390-6. [DOI: 10.1097/mcc.0b013e3283021b3a] [Cited by in Crossref: 68] [Cited by in F6Publishing: 27] [Article Influence: 4.9] [Reference Citation Analysis]
43 Hoen B, Varon E, de Debroucker T, Fantin B, Grimprel E, Wolff M, Duval X. Management of acute community-acquired bacterial meningitis (excluding newborns). Long version with arguments. Médecine et Maladies Infectieuses 2019;49:405-41. [DOI: 10.1016/j.medmal.2019.03.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
44 Cai Y, Zhou L, Wang H, Zhang L, Wang J, Zhang K. Comparation of vancomycin penetration into cerebrospinal fluid in postoperative intracranial infection and community-acquired meningitis patients. J Clin Pharm Ther 2019;44:216-9. [DOI: 10.1111/jcpt.12770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
45 van de Beek D, Brouwer MC, Thwaites GE, Tunkel AR. Advances in treatment of bacterial meningitis. The Lancet 2012;380:1693-702. [DOI: 10.1016/s0140-6736(12)61186-6] [Cited by in Crossref: 176] [Cited by in F6Publishing: 70] [Article Influence: 17.6] [Reference Citation Analysis]
46 Hameed N, Tunkel AR. Treatment of Drug-resistant Pneumococcal Meningitis. Curr Infect Dis Rep. 2010;12:274-281. [PMID: 21308542 DOI: 10.1007/s11908-010-0110-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
47 Ishikawa M, Yamazaki S, Suzuki T, Uchida M, Iwadate Y, Ishii I. Correlation between vancomycin penetration into cerebrospinal fluid and protein concentration in cerebrospinal fluid/serum albumin ratio. J Infect Chemother 2019;25:124-8. [PMID: 30424949 DOI: 10.1016/j.jiac.2018.10.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
48 van Maarseveen EM, Gipmans SGH, van Zanten ARH. Exposure Variability and Target Attainment of Vancomycin: A Systematic Review Comparing Intermittent and Continuous Infusion. Therapeutic Drug Monitoring 2020;42:381-91. [DOI: 10.1097/ftd.0000000000000755] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
49 Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Scheld WM, van de Beek D, Bleck TP, Zunt JR. Reply to Marx et al. Clin Infect Dis 2017;65:1429-30. [PMID: 28633345 DOI: 10.1093/cid/cix554] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Onufrak NJ, Forrest A, Gonzalez D. Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing. Clin Ther 2016;38:1930-47. [PMID: 27449411 DOI: 10.1016/j.clinthera.2016.06.015] [Cited by in Crossref: 65] [Cited by in F6Publishing: 52] [Article Influence: 10.8] [Reference Citation Analysis]
51 Tsai HC, Chen YS, Lee SS, Lin YH, Wann SR, Sy CL, Liu YC. Hepatocyte growth factor level in cerebrospinal fluid as an additional marker in patient with drug-resistant streptococcus pneumoniae meningitis treated with linezolid. Clin Med Case Rep 2008;1:53-5. [PMID: 24179347 DOI: 10.4137/ccrep.s759] [Reference Citation Analysis]
52 Young N, Thomas M. Meningitis in adults: diagnosis and management. Intern Med J 2018;48:1294-307. [PMID: 30387309 DOI: 10.1111/imj.14102] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
53 Heffernan AJ, Roberts JA. Dose optimisation of antibiotics used for meningitis. Curr Opin Infect Dis 2021;34:581-90. [PMID: 34534985 DOI: 10.1097/QCO.0000000000000783] [Reference Citation Analysis]
54 Djukic M, Munz M, Sörgel F, Holzgrabe U, Eiffert H, Nau R. Overton's rule helps to estimate the penetration of anti-infectives into patients' cerebrospinal fluid. Antimicrob Agents Chemother 2012;56:979-88. [PMID: 22106225 DOI: 10.1128/AAC.00437-11] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
55 Arnell K, Cesarini K, Lagerqvist-Widh A, Wester T, Sjölin J. Cerebrospinal fluid shunt infections in children over a 13-year period: anaerobic cultures and comparison of clinical signs of infection with Propionibacterium acnes and with other bacteria. J Neurosurg Pediatr 2008;1:366-72. [PMID: 18447670 DOI: 10.3171/PED/2008/1/5/366] [Cited by in Crossref: 66] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
56 Elyasi S, Khalili H, Dashti-Khavidaki S, Emadi-Koochak H. Conventional- versus high-dose vancomycin regimen in patients with acute bacterial meningitis: a randomized clinical trial. Expert Opin Pharmacother 2015;16:297-304. [PMID: 25547064 DOI: 10.1517/14656566.2015.999042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
57 Li J, He S, Yang Z, Lu C. Pharmacokinetics and cerebrospinal fluid penetration of norvancomycin in Chinese adult patients. Int J Antimicrob Agents 2017;49:603-8. [PMID: 28366660 DOI: 10.1016/j.ijantimicag.2017.01.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
58 Ali M, Usman M, Rasheed H, Hempel G, Nawaz HA, Hanif M, Rasool F, Saleem M. A systematic review on chromatography-based method validation for quantification of vancomycin in biological matrices. Bioanalysis 2020;12:1767-86. [PMID: 33275028 DOI: 10.4155/bio-2020-0230] [Reference Citation Analysis]
59 Jalusic KO, Hempel G, Arnemann PH, Spiekermann C, Kampmeier TG, Ertmer C, Gastine S, Hessler M. Population pharmacokinetics of vancomycin in patients with external ventricular drain-associated ventriculitis. Br J Clin Pharmacol 2021;87:2502-10. [PMID: 33202067 DOI: 10.1111/bcp.14657] [Reference Citation Analysis]
60 Liechti FD, Grandgirard D, Leib SL. Bacterial meningitis: insights into pathogenesis and evaluation of new treatment options: a perspective from experimental studies. Future Microbiol 2015;10:1195-213. [PMID: 26119836 DOI: 10.2217/fmb.15.43] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
61 Mounier R, Lobo D, Hulin A, Nebbad B, Cook F, Dhonneur G. Is First-Line Vancomycin Still the Best Option to Treat Staphylococcus Health Care-Associated Meningitis? World Neurosurg 2017;99:812.e1-5. [PMID: 28034813 DOI: 10.1016/j.wneu.2016.12.076] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
62 Kino H, Suzuki H, Yamaguchi T, Notake S, Oishi T, Ito Y, Nakamura K, Miyazaki H, Matsumoto T, Uemura K, Matsumura A. Central nervous system infection caused by vancomycin-intermediate Staphylococcus aureus (SCCmec type IV, ST8). J Infect Chemother 2014;20:643-6. [PMID: 25012468 DOI: 10.1016/j.jiac.2014.06.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
63 Bravo T, Bhimraj A. Healthcare-Acquired Meningitis and Ventriculitis. In: Hasbun R, editor. Meningitis and Encephalitis. Cham: Springer International Publishing; 2018. pp. 27-42. [DOI: 10.1007/978-3-319-92678-0_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
64 Klein M, Pfister H, Leib S, Koedel U. Therapy of community-acquired acute bacterial meningitis: the clock is running. Expert Opinion on Pharmacotherapy 2009;10:2609-23. [DOI: 10.1517/14656560903277210] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
65 Chavanet P. [Presumptive bacterial meningitis in adults: initial antimicrobial therapy]. Med Mal Infect 2009;39:499-512. [PMID: 19428207 DOI: 10.1016/j.medmal.2009.02.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
66 Ebot J, Freeman WD, Wharen R, Diaz MA, Libertin C. MRSA Spinal Epidural Abscess as a Neurosurgical and Infectious Disease Emergency with Unresolved Antimicrobial Solution. Case Rep Infect Dis 2019;2019:7413089. [PMID: 30838147 DOI: 10.1155/2019/7413089] [Reference Citation Analysis]
67 Gonzalez-Granado LI. Acute bacterial meningitis. Lancet Infect Dis 2010;10:596. [PMID: 20797642 DOI: 10.1016/S1473-3099(10)70184-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
68 Lonsdale DO, Udy AA, Roberts JA, Lipman J. Antibacterial therapeutic drug monitoring in cerebrospinal fluid: difficulty in achieving adequate drug concentrations. J Neurosurg 2013;118:297-301. [PMID: 23121433 DOI: 10.3171/2012.10.JNS12883] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
69 McGill F, Heyderman RS, Michael BD, Defres S, Beeching NJ, Borrow R, Glennie L, Gaillemin O, Wyncoll D, Kaczmarski E, Nadel S, Thwaites G, Cohen J, Davies NW, Miller A, Rhodes A, Read RC, Solomon T. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect 2016;72:405-38. [PMID: 26845731 DOI: 10.1016/j.jinf.2016.01.007] [Cited by in Crossref: 84] [Cited by in F6Publishing: 70] [Article Influence: 14.0] [Reference Citation Analysis]
70 Bretonnière C, Jozwiak M, Girault C, Beuret P, Trouillet JL, Anguel N, Caillon J, Potel G, Villers D, Boutoille D, Guitton C. Rifampin use in acute community-acquired meningitis in intensive care units: the French retrospective cohort ACAM-ICU study. Crit Care 2015;19:303. [PMID: 26306393 DOI: 10.1186/s13054-015-1021-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
71 Beach JE, Perrott J, Turgeon RD, Ensom MHH. Penetration of Vancomycin into the Cerebrospinal Fluid: A Systematic Review. Clin Pharmacokinet. 2017;56:1479-1490. [PMID: 28528396 DOI: 10.1007/s40262-017-0548-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
72 DE Gaudio M, Chiappini E, Galli L, DE Martino M. Therapeutic management of bacterial meningitis in children: a systematic review and comparison of published guidelines from a European perspective. J Chemother 2010;22:226-37. [PMID: 20685625 DOI: 10.1179/joc.2010.22.4.226] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
73 Principi N, Esposito S. Bacterial meningitis: new treatment options to reduce the risk of brain damage. Expert Opin Pharmacother 2020;21:97-105. [PMID: 31675255 DOI: 10.1080/14656566.2019.1685497] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]